Folate concentrations in pediatric patients with newly diagnosed inflammatory bowel disease

Melvin B Heyman1, Elizabeth A Garnett, Nishat Shaikh

  • 1Department of Pediatrics, University of California, San Francisco, San Francisco, CA 94143-0136, USA. mheyman@peds.ucsf.edu

Insights

Children newly diagnosed with inflammatory bowel disease (IBD) showed higher folate levels than healthy children, contrary to expectations. Further research is needed to understand the implications of these elevated folate concentrations in pediatric IBD.

Area of Science:

  • Pediatric Gastroenterology
  • Nutritional Science
  • Biochemistry

Background:

  • Folate plays a role in preventing cell injury and cancer risk.
  • Folate deficiency is linked to inflammatory bowel disease (IBD).
  • Folate levels in children with IBD are not well-understood.

Purpose of the Study:

  • To compare folate concentrations in children with newly diagnosed IBD versus healthy controls.

Main Methods:

  • Measured red blood cell folate (RBCF) and whole-blood folate (WBF) in 78 children (22 IBD, 41 controls).
  • Recorded vitamin supplementation and dietary intake via food-frequency questionnaire.
  • Included children with Crohn disease, ulcerative colitis, and indeterminate colitis.

Main Results:

  • Children with newly diagnosed IBD had significantly higher RBCF (19.4% higher) and WBF (11.1% higher) than controls.
  • Total folate intake was higher in controls, but not statistically significant.
  • A notable percentage of all subjects had folate intake below the Recommended Dietary Allowance.

Conclusions:

  • Contrary to adult studies, newly diagnosed pediatric IBD patients exhibited higher folate concentrations.
  • This finding was unexpected given higher dietary folate intake and hematocrit in controls.
  • Further investigation is required on IBD therapy's impact on folate metabolism and long-term clinical significance of high folate levels at diagnosis.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...